Ana Belén Herrero

7PUBLICATIONS
24CO-AUTHORS
Metabolomic chemistryMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2023
Autophagy, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications.

Daniel Salete-Granado, Cristina Carbonell, David Puertas-Miranda

|Jan 21, 2023
DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities.

María Ovejero-Sánchez, Rogelio González-Sarmiento, Ana Belén Herrero

|Nov 11, 2022
Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells.

María Ovejero-Sánchez, Gloria Asensio-Juárez, Myriam González

|Aug 26, 2022
Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.

Jésica Pérez-García, Abel Martel-Martel, Paula García-Vallés

|Jul 27, 2022
Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity.

María Ovejero-Sánchez, Jorge Rubio-Heras, María Del Carmen Vicente de la Peña

|Mar 06, 2021
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.

Myriam González, María Ovejero-Sánchez, Alba Vicente-Blázquez

Pageof 2

Frequent Collaborators

5 joint publications

Rogelio González-Sarmiento

4 joint publications

María Ovejero-Sánchez

2 joint publications

Rafael Peláez

2 joint publications

Luis Antonio Corchete